top of page
A NEW GENERATION OF IMMUNOTHERAPIES
The Latest Press Releases
AUGUST 1, 2022
AyuVis Selected for MassChallenge Accelerator 2022 Cohort
MAY 13, 2022
AyuVis Awarded $1.8M Grant to Support Pediatric Drug Development Program
MARCH 31, 2022
AyuVis Receives Second Patent Approval from USPTO, Australia
February 13, 2022
Startup AyuVis’ First Patent Granted in U.S., 3 Other Countries
bottom of page